- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
LivaNova PLC (LIVN)
LivaNova PLC stock price live, this page displays NASDAQ LIVN stock exchange data. View the LIVN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the LivaNova PLC real time stock price chart below.
What Is the LivaNova PLC Stock Price Today?
The LivaNova PLC stock price today is 73.64.
What Is the Stock Symbol for LivaNova PLC?
The stock symbol for LivaNova PLC is "LIVN."
What Stock Exchange Does LivaNova PLC Trade On?
LivaNova PLC is listed and trades on the NASDAQ stock exchange.
Is LivaNova PLC a Good Stock to Buy?
Determining whether LivaNova PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LIVN quote. (ISIN: GB00BYMT0J19)
What Is the LivaNova PLC Stock Price Today?
The LivaNova PLC stock price today is 73.64.
What Is the Stock Symbol for LivaNova PLC?
The stock symbol for LivaNova PLC is "LIVN."
What Stock Exchange Does LivaNova PLC Trade On?
LivaNova PLC is listed and trades on the NASDAQ stock exchange.
Is LivaNova PLC a Good Stock to Buy?
Determining whether LivaNova PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LIVN quote. (ISIN: GB00BYMT0J19)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
71.57
74.07
52 wk Range
41.02
74.32
LIVN is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
71.5774.07
52 wk Range
41.0274.32
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
LIVN Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
80.18
Upside
+8.88%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
- LivaNova PLC receives Investment Bank Analyst Rating Update
- Investing.com
Pro - LivaNova PLC receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- LivaNova stock hits 52-week high at 73.31 USD
- Investing.com
- LivaNova stock hits 52-week high at 71.97 USD
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
8 Buy
3 Hold
0 Sell
Ratings:
11 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 80.18
(+8.88% Upside)
LivaNova PLC SWOT Analysis
Cardio Innovation | LivaNova's Essenz heart-lung machine leads a "generational product cycle," poised to drive significant growth through 2027 in the cardiopulmonary market |
Financial Pulse | Analysts project 6-7% organic growth, with potential to exceed in 2025. Price targets range from $56 to $80, suggesting upside potential |
Pipeline Prospects | Explore LivaNova's diversification strategy with promising developments in sleep apnea and depression treatments, potentially opening new revenue streams |
Market Challenges | Delve into LivaNova's navigation of mature franchises, regulatory hurdles, and legal uncertainties, balancing innovation against competitive pressures |
LivaNova PLC Earnings Call Summary for Q1/2026
- LivaNova Q1 2026 revenue hit $362.3M (up 11% YoY); adjusted EPS of $0.98 beat estimates by 8.89%, driving shares up 6.34% premarket.
- Cardiopulmonary segment surged 14% YoY on strong heart-lung machine demand; epilepsy segment grew 8% from market share gains and pricing.
- Adjusted gross margin dipped to 68% from 69% YoY; operating income rose to $71M from $65M as company expands manufacturing capacity.
- Management forecasts Q2-Q3 EPS of $1.12-$1.18; plans next-gen oxygenator launch in 2028 to sustain growth momentum.
- Key risks include supply chain constraints, currency headwinds, regulatory changes, and rising competition in cardiopulmonary markets.
Last Updated: 2026-05-06, 09:34 a/m
Read Full TranscriptEarnings
Latest Release
May 06, 2026
EPS / Forecast
0.98 / 0.90
Revenue / Forecast
362.3M / 346.06M
Compare LIVN to Peers and Sector
Metrics to compare | LIVN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLIVNPeersSector | |
|---|---|---|---|---|
P/E Ratio | 37.8x | 14.2x | −0.5x | |
PEG Ratio | 0.26 | −1.18 | 0.00 | |
Price/Book | 3.3x | 3.2x | 2.6x | |
Price / LTM Sales | 2.8x | 3.6x | 3.1x | |
Upside (Analyst Target) | 8.5% | 22.9% | 53.0% | |
Fair Value Upside | Unlock | 25.6% | 6.3% | Unlock |
LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services in the United States, the United Kingdom, Germany, France, Italy, the Netherlands, Spain, Belgium, Poland, Sweden, Switzerland, Austria, Norway, Portugal, Finland, Denmark, and internationally. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannulae, and other related accessories, as well as services related products. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals; and devices that deliver neuromodulation therapy for treating drug-resistant epilepsy and difficult-to-treat depression. This segment also includes the development and clinical testing of LivaNova’s aura6000 system for treating obstructive sleep apnea. It serves perfusionists, neurologists, neurosurgeons, and other healthcare professionals, hospitals, and other medical institutions and healthcare providers. The company sells its medical devices through a combination of direct sales representatives, agents, and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the LivaNova PLC (LIVN) Stock Price Today?
The LivaNova PLC stock price today is 73.64 USD.
What Stock Exchange Does LivaNova PLC Trade On?
LivaNova PLC is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for LivaNova PLC?
The stock symbol for LivaNova PLC is "LIVN."
What Is the LivaNova PLC Market Cap?
As of today, LivaNova PLC market cap is 4.05B USD.
What Is LivaNova PLC's Earnings Per Share (TTM)?
The LivaNova PLC EPS (TTM) is 1.94.
When Is the Next LivaNova PLC Earnings Date?
LivaNova PLC will release its next earnings report on Jul 29, 2026.
From a Technical Analysis Perspective, Is LIVN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has LivaNova PLC Stock Split?
LivaNova PLC has split 0 times.
How Many Employees Does LivaNova PLC Have?
LivaNova PLC has 3300 employees.
What is the current trading status of LivaNova PLC (LIVN)?
As of May 22, 2026, LivaNova PLC (LIVN) is trading at a price of 73.64 USD, with a previous close of 73.64 USD. The stock has fluctuated within a day range of 71.57 USD to 74.07 USD, while its 52-week range spans from 41.02 USD to 74.32 USD.
What Is LivaNova PLC (LIVN) Price Target According to Analysts?
The average 12-month price target for LivaNova PLC is 80.18 USD, with a high estimate of 95 USD and a low estimate of 67 USD. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +8.88% Upside potential.
What Is the LIVN Premarket Price?
LIVN's last pre-market stock price is 74.50 USD. The pre-market share volume is 460.00, and the stock has decreased by 0.86, or 1.17%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.